BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 32072427)

  • 21. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes.
    Sin O; Nollen EA
    Cell Mol Life Sci; 2015 Nov; 72(21):4027-47. PubMed ID: 26190021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of protein clearance mechanisms in organismal ageing and age-related diseases.
    Vilchez D; Saez I; Dillin A
    Nat Commun; 2014 Dec; 5():5659. PubMed ID: 25482515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding.
    Yakubu UM; Morano KA
    Biol Chem; 2018 Sep; 399(10):1215-1221. PubMed ID: 29908125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases.
    Cuanalo-Contreras K; Moreno-Gonzalez I
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein homeostasis as a therapeutic target for diseases of protein conformation.
    Calamini B; Morimoto RI
    Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions.
    Panwar S; Uniyal P; Kukreti N; Hashmi A; Verma S; Arya A; Joshi G
    Chem Biol Drug Des; 2024 Apr; 103(4):e14515. PubMed ID: 38570333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    Garcia Manriquez BA; Papapanagiotou JA; Strysick CA; Green EH; Kikis EA
    PLoS One; 2023; 18(2):e0275137. PubMed ID: 36821635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective proteostasis in Alzheimer's disease.
    Cozachenco D; Ribeiro FC; Ferreira ST
    Ageing Res Rev; 2023 Mar; 85():101862. PubMed ID: 36693451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
    Sonninen TM; Goldsteins G; Laham-Karam N; Koistinaho J; Lehtonen Š
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does proteostasis get lost in translation? Implications for protein aggregation across the lifespan.
    Francisco S; Ferreira M; Moura G; Soares AR; Santos MAS
    Ageing Res Rev; 2020 Sep; 62():101119. PubMed ID: 32603841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intrinsic and extrinsic factors that contribute to proteostasis decline and pathological protein misfolding.
    Kikis EA
    Adv Protein Chem Struct Biol; 2019; 118():145-161. PubMed ID: 31928724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shaping proteostasis at the cellular, tissue, and organismal level.
    Sala AJ; Bott LC; Morimoto RI
    J Cell Biol; 2017 May; 216(5):1231-1241. PubMed ID: 28400444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chaperone Grp78 in protein folding disorders of the nervous system.
    Moreno JA; Tiffany-Castiglioni E
    Neurochem Res; 2015 Feb; 40(2):329-35. PubMed ID: 25107299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM family proteins: roles in proteostasis and neurodegenerative diseases.
    Zhu Y; Afolabi LO; Wan X; Shim JS; Chen L
    Open Biol; 2022 Aug; 12(8):220098. PubMed ID: 35946309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteostasis regulation by the ubiquitin system.
    Bett JS
    Essays Biochem; 2016 Oct; 60(2):143-151. PubMed ID: 27744330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.